Chapter 8 The Roles and Action Mechanisms of p160/SRC Coactivators and the ANCCA Coregulator in Cancer

Elaine Y C Hsia, June X Zou, Hongwu Chen

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Chromosomal aberrations involving genes encoding members of the p160/SRC transcriptional coactivator family such as AIB1/ACTR and TIF2 implicated the coactivators in malignancy of human cells. Significant progress has been made in the last decade toward uncovering their roles in the development and progression of solid tissue tumors as well as leukemia and understanding of the underlying molecular mechanisms. Here, we review their genetic aberrations and dysregulation in expression in breast cancer, prostate cancer, and other nonhormone-responsive cancers. The experimental evidence gathered from studies using cell culture and animal models strongly supports a critical and, in some circumstances, their oncogenic function. We summarize results that the SRCs may contribute to tumorigenesis and disease progression through transcription factors such as E2F, PEA3, and AP-1 and through an intimate control of signaling pathways of growth factors-Akt and the receptor tyrosine kinases. The finding that a recently identified nuclear receptor coregulator ANCCA, like the SRCs, is frequently overexpressed in many types of cancers again underscores their broader roles in cancer.

Original languageEnglish (US)
Pages (from-to)261-298
Number of pages38
JournalProgress in Molecular Biology and Translational Science
Volume87
Issue numberC
DOIs
StatePublished - 2009

Fingerprint

Neoplasms
Prostatic Neoplasms
Growth Factor Receptors
Transcription Factor AP-1
Cytoplasmic and Nuclear Receptors
Chromosome Aberrations
Protein-Tyrosine Kinases
Disease Progression
Carcinogenesis
Leukemia
Transcription Factors
Animal Models
Cell Culture Techniques
Breast Neoplasms
Genes

ASJC Scopus subject areas

  • Molecular Biology
  • Molecular Medicine

Cite this

Chapter 8 The Roles and Action Mechanisms of p160/SRC Coactivators and the ANCCA Coregulator in Cancer. / Hsia, Elaine Y C; Zou, June X; Chen, Hongwu.

In: Progress in Molecular Biology and Translational Science, Vol. 87, No. C, 2009, p. 261-298.

Research output: Contribution to journalArticle

@article{69493606575f4436ae32ccb7810b85be,
title = "Chapter 8 The Roles and Action Mechanisms of p160/SRC Coactivators and the ANCCA Coregulator in Cancer",
abstract = "Chromosomal aberrations involving genes encoding members of the p160/SRC transcriptional coactivator family such as AIB1/ACTR and TIF2 implicated the coactivators in malignancy of human cells. Significant progress has been made in the last decade toward uncovering their roles in the development and progression of solid tissue tumors as well as leukemia and understanding of the underlying molecular mechanisms. Here, we review their genetic aberrations and dysregulation in expression in breast cancer, prostate cancer, and other nonhormone-responsive cancers. The experimental evidence gathered from studies using cell culture and animal models strongly supports a critical and, in some circumstances, their oncogenic function. We summarize results that the SRCs may contribute to tumorigenesis and disease progression through transcription factors such as E2F, PEA3, and AP-1 and through an intimate control of signaling pathways of growth factors-Akt and the receptor tyrosine kinases. The finding that a recently identified nuclear receptor coregulator ANCCA, like the SRCs, is frequently overexpressed in many types of cancers again underscores their broader roles in cancer.",
author = "Hsia, {Elaine Y C} and Zou, {June X} and Hongwu Chen",
year = "2009",
doi = "10.1016/S1877-1173(09)87008-7",
language = "English (US)",
volume = "87",
pages = "261--298",
journal = "Progress in Molecular Biology and Translational Science",
issn = "1877-1173",
publisher = "Academic Press Inc.",
number = "C",

}

TY - JOUR

T1 - Chapter 8 The Roles and Action Mechanisms of p160/SRC Coactivators and the ANCCA Coregulator in Cancer

AU - Hsia, Elaine Y C

AU - Zou, June X

AU - Chen, Hongwu

PY - 2009

Y1 - 2009

N2 - Chromosomal aberrations involving genes encoding members of the p160/SRC transcriptional coactivator family such as AIB1/ACTR and TIF2 implicated the coactivators in malignancy of human cells. Significant progress has been made in the last decade toward uncovering their roles in the development and progression of solid tissue tumors as well as leukemia and understanding of the underlying molecular mechanisms. Here, we review their genetic aberrations and dysregulation in expression in breast cancer, prostate cancer, and other nonhormone-responsive cancers. The experimental evidence gathered from studies using cell culture and animal models strongly supports a critical and, in some circumstances, their oncogenic function. We summarize results that the SRCs may contribute to tumorigenesis and disease progression through transcription factors such as E2F, PEA3, and AP-1 and through an intimate control of signaling pathways of growth factors-Akt and the receptor tyrosine kinases. The finding that a recently identified nuclear receptor coregulator ANCCA, like the SRCs, is frequently overexpressed in many types of cancers again underscores their broader roles in cancer.

AB - Chromosomal aberrations involving genes encoding members of the p160/SRC transcriptional coactivator family such as AIB1/ACTR and TIF2 implicated the coactivators in malignancy of human cells. Significant progress has been made in the last decade toward uncovering their roles in the development and progression of solid tissue tumors as well as leukemia and understanding of the underlying molecular mechanisms. Here, we review their genetic aberrations and dysregulation in expression in breast cancer, prostate cancer, and other nonhormone-responsive cancers. The experimental evidence gathered from studies using cell culture and animal models strongly supports a critical and, in some circumstances, their oncogenic function. We summarize results that the SRCs may contribute to tumorigenesis and disease progression through transcription factors such as E2F, PEA3, and AP-1 and through an intimate control of signaling pathways of growth factors-Akt and the receptor tyrosine kinases. The finding that a recently identified nuclear receptor coregulator ANCCA, like the SRCs, is frequently overexpressed in many types of cancers again underscores their broader roles in cancer.

UR - http://www.scopus.com/inward/record.url?scp=77957097625&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957097625&partnerID=8YFLogxK

U2 - 10.1016/S1877-1173(09)87008-7

DO - 10.1016/S1877-1173(09)87008-7

M3 - Article

C2 - 20374707

AN - SCOPUS:77957097625

VL - 87

SP - 261

EP - 298

JO - Progress in Molecular Biology and Translational Science

JF - Progress in Molecular Biology and Translational Science

SN - 1877-1173

IS - C

ER -